Cargando…
The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis
Autores principales: | Parikh, Sameer A., Achenbach, Sara J., Rabe, Kari G., Norman, Aaron D., Boddicker, Nicholas J., Olson, Janet E., Call, Timothy G., Cerhan, James R., Vachon, Celine M., Kay, Neil E., Braggio, Esteban, Hanson, Curtis A., Slager, Susan L., Shanafelt, Tait D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684458/ https://www.ncbi.nlm.nih.gov/pubmed/36418344 http://dx.doi.org/10.1038/s41408-022-00754-x |
Ejemplares similares
-
Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis
por: Boddicker, Nicholas J., et al.
Publicado: (2022) -
Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans
por: Kleinstern, Geffen, et al.
Publicado: (2021) -
Progression and survival of MBL: a screening study of 10 139 individuals
por: Slager, Susan L., et al.
Publicado: (2022) -
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
por: Parikh, Sameer A., et al.
Publicado: (2021) -
Risk of Non-hematologic Cancer in Individuals with High Count Monoclonal B-Cell Lymphocytosis (MBL)
por: Solomon, Benjamin M., et al.
Publicado: (2015)